Physician profile
Li Lu
NPI 1770883787
$6,537.24
in general payments reported to CMS, 2019-2025
26 companies · $705 in 2025
The $705 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,128 · 2020: $278 · 2021: $840 · 2022: $1,153 · 2023: $1,314 · 2024: $1,120 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,137.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,459.65 | 2019-2025 | Vemlidy |
| Merz North America, INC. | $696.50 | 2022-2025 | Xeomin |
| Astrazeneca Pharmaceuticals Lp | $507.88 | 2019-2025 | Airsupra, Farxiga |
| Abbvie INC. | $490.59 | 2019-2025 | |
| Amarin Pharma, INC. | $450.95 | 2019-2022 | |
| Glaxosmithkline, LLC. | $379.34 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Otsuka America Pharmaceutical, INC. | $366.29 | 2019-2023 | Jynarque |
| Novo Nordisk INC | $364.34 | 2019-2022 | |
| Lilly USA, LLC | $331.54 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Merck Sharp & Dohme LLC | $274.62 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Angiodynamics, INC. | $260.48 | 2024 | Angiodynamics, Nanoknife |
| Pfizer INC. | $160.24 | 2019-2024 | |
| Amgen INC. | $130.11 | 2019-2024 | Repatha, Otezla, Evenity |
| Axsome Therapeutics, INC. | $122.53 | 2024 | Auvelity |
| Biohaven Pharmaceutical Holding Company Ltd. | $99.61 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $85.83 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.16 | 2021-2024 | Jardiance |
| Exact Sciences Corporation | $66.70 | 2025 | Cologuard Collection Kit |
| Vbi Vaccine (Delaware) INC. | $63.14 | 2022 | |
| Agios Pharmaceuticals, INC. | $42.31 | 2024 | Pyrukynd |
| Renalytix Ai, INC. | $23.69 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Shield Therapeutics INC | $22.95 | 2024 | |
| Hologic Sales and Service, LLC | $18.01 | 2021 | |
| Horizon Therapeutics Plc | $16.25 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.42 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.11 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Li Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.